Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells

Oncotarget

Volumn 7, Issue 3, 2016, Pages 2508-2518

  Steinbichler, Teresa Bernadette ^a   Metzler, Veronika ^a   Pritz, Christian ^a   Riechelmann, Herbert ^a   Dudas, Jozsef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cancer associated fibroblasts; Chemoresistance; Cisplatin; Epithelial to mesenchymal transition; TGF 1

Indexed keywords

CISPLATIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; ANTINEOPLASTIC AGENT; CONDITIONED MEDIUM; MESSENGER RNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IC50; PHENOTYPE; SQUAMOUS CELL CARCINOMA CELL LINE; TREATMENT RESPONSE; UPREGULATION; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; COCULTURE; CONDITIONED MEDIUM; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; HEAD AND NECK NEOPLASMS; PATHOLOGY; PHARMACOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CISPLATIN; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GINGIVA; HEAD AND NECK NEOPLASMS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 84962318040     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6210     Document Type: Article

References (35)

1. Dudas J, Bitsche M, Schartinger V, Falkeis C, Sprinzl GM, Riechelmann H. Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells. Oral oncology. 2011;47:98-103.
2. Radisky DC. Fibroblasts act as co-conspirators for chemotherapy resistance. Cancer biology & therapy. 2008;7:1348-9.
3. Smith A, Teknos TN, Pan Q. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral oncology. 2013;49:287-92.
4. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell cycle. 2006;5:1597-601.
5. Fullar A, Kovalszky I, Bitsche M, Romani A, Schartinger VH, Sprinzl GM, Riechelmann H, Dudas J. Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Experimental cell research. 2012;318:1517-27.
6. Xu LN, Xu BN, Cai J, Yang JB, Lin N. Tumor-associated fibroblast-conditioned medium promotes tumor cell proliferation and angiogenesis. Genetics and molecular research: GMR. 2013;12:5863-71.
7. Katsuno Y, Lamouille S, Derynck R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Current opinion in oncology. 2013;25:76-84.
8. Dudas J, Fullar A, Romani A, Pritz C, Kovalszky I, Hans Schartinger V, Sprinzl GM, Riechelmann H. Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma. Experimental cell research. 2013;319:800-9.
9. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer research. 1981;41:1657-63.
10. Chen YW, Lin GJ, Chia WT, Lin CK, Chuang YP, Sytwu HK. Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo. Oral oncology. 2009;45:562-8.
11. Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clinical cancer research. 2011;17:6658-70.
12. Peterson WD, Jr., Stulberg CS, Simpson WF. A permanent heteroploid human cell line with type B glucose-6-phosphate dehydrogenase. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. 1971;136:1187-91.
13. Peterson WD, Jr., Stulberg CS, Swanborg NK, Robinson AR. Glucose-6-phosphate dehydrogenase isoenzymes in human cell cultures determined by sucrose-agar gel and cellulose acetate zymograms. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. 1968;128:772-6.
14. Puck TT, Marcus PI. Action of x-rays on mammalian cells. The Journal of experimental medicine. 1956;103:653-66.
15. Paraiso KH, Smalley KS. Fibroblast-mediated drug resistance in cancer. Biochemical pharmacology. 2013;85:1033-41.
16. Buchmaier BS, Bibi A, Muller GA, Dihazi GH, Eltoweissy M, Kruegel J, Dihazi H. Renal cells express different forms of vimentin: the independent expression alteration of these forms is important in cell resistance to osmotic stress and apoptosis. PloS one. 2013;8:e68301.
17. Dudas J, Fullar A, Bitsche M, Schartinger V, Kovalszky I, Sprinzl GM, Riechelmann H. Tumor-produced, active interleukin-1beta regulates gene expression in carcinoma-associated fibroblasts. Experimental cell research. 2011;317:2222-9.
18. Hassona Y, Cirillo N, Heesom K, Parkinson EK, Prime SS. Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion. British journal of cancer. 2014;111:1230-7.
19. Liu Y, Zhang M, Qian J, Bao M, Meng X, Zhang S, Zhang L, Zhao R, Li S, Cao Q, Li P, Ju X, Lu Q, et al. miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells. DNA and cell biology. 2015.
20. Martin D, Abba MC, Molinolo AA, Vitale-Cross L, Wang Z, Zaida M, Delic NC, Samuels Y, Lyons JG, Gutkind JS. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies. Oncotarget. 2014;5:8906-23.
21. Flach EH, Rebecca VW, Herlyn M, Smalley KS, Anderson AR. Fibroblasts contribute to melanoma tumor growth and drug resistance. Molecular pharmaceutics. 2011;8:2039-49.
22. Niessner H, Forschner A, Klumpp B, Honegger JB, Witte M, Bornemann A, Dummer R, Adam A, Bauer J, Tabatabai G, Flaherty K, Sinnberg T, Beck D et al. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer medicine. 2013;2:76-85.
23. Bartling B, Hofmann HS, Silber RE, Simm A. Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin. Cancer biology & therapy. 2008;7:1250-61.
24. Gilbert LA, Hemann MT. DNA damage-mediated induction of a chemoresistant niche. Cell. 2010;143:355-66.
25. Docheva D, Padula D, Popov C, Weishaupt P, Pragert M, Miosge N, Hickel R., Bocker W., Clausen-Schaumann H., Schieker M. Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. European cells & materials. 2010;19:228-41.
26. Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P. The Hill equation: a review of its capabilities in pharmacological modelling. Fundamental & clinical pharmacology. 2008;22:633-48.
27. Schartinger VH, Galvan O, Riechelmann H, Dudas J. Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2012;20:523-9.
28. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, et al. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012;9:676-82.
29. Sternberg B. Exploring the potential of computer-assisted medical illustration. Biomedical communications. 1983;11:28-31.
30. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Analytical and quantitative cytology and histology/the International Academy of Cytology [and] American Society of Cytology. 2001;23:291-9.
31. Zack GW, Rogers WE, Latt SA. Automatic measurement of sister chromatid exchange frequency. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 1977;25:741-53.
32. Li CH, Lee C.K. Minimum Croos Entropy Thresholding. Pattern Recognition. 1993;26:617-25.
33. Kapur JN, Sahoo PK, Wong AKC. A new method for gray-level picture thresholding using the entropy of the histogram. Computer Vision, Graphics, and Image Processing. 1985;29:273-85.
34. N. O. A treshold Selection Method from Gray-Level Histograms. IEEE Transactions on Systems, Man, and Cybernetics. 1979;1:62-6.
35. Shanbhag AG. Utilization of Information Measure as a Means of Image Thresholding. CVGIP: Graphical Models and Image Processing. 1994;56:414-9.